Accueil
Envoyer à un ami
Imprimer
Grand
Petit
Partager
ACTUALITES

Novartis International AG - Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL


- 4 Décembre 2016 modifié le 1 Janvier 1970


Novartis International AG / Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

Source : http://www.romandie.com/news/Novartis-Internationa...